Does TOCILIZUMAB Cause Joint effusion? 391 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 391 reports of Joint effusion have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.4% of all adverse event reports for TOCILIZUMAB.
391
Reports of Joint effusion with TOCILIZUMAB
0.4%
of all TOCILIZUMAB reports
18
Deaths
187
Hospitalizations
How Dangerous Is Joint effusion From TOCILIZUMAB?
Of the 391 reports, 18 (4.6%) resulted in death, 187 (47.8%) required hospitalization, and 65 (16.6%) were considered life-threatening.
Is Joint effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 391 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Joint effusion?
ADALIMUMAB (1,367)
METHOTREXATE (917)
ETANERCEPT (826)
TOFACITINIB (520)
LEFLUNOMIDE (407)
HYDROXYCHLOROQUINE (380)
INFLIXIMAB (372)
RITUXIMAB (368)
PREDNISONE (357)
ABATACEPT (349)
Which TOCILIZUMAB Alternatives Have Lower Joint effusion Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE